Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for aging biomarkers in pre-diabetes
NCT04401904Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in aging, sponsored by UT Health San Antonio. Started Jun 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
aging
Beyond the preview
Go deeper on NCT04401904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401904.